Massively parallel reporter assays of melanoma risk variants identify MX2 as a gene promoting melanoma

There are more than 20 known melanoma susceptibility genes. Here, using a massively parallel reporter assay, the authors identify risk-associated variants that alter gene transcription, and demonstrate that expression of one such gene, MX2, leads to the promotion of melanoma in a zebrafish model.

Bibliographic Details
Main Authors: Jiyeon Choi, Tongwu Zhang, Andrew Vu, Julien Ablain, Matthew M. Makowski, Leandro M. Colli, Mai Xu, Rebecca C. Hennessey, Jinhu Yin, Harriet Rothschild, Cathrin Gräwe, Michael A. Kovacs, Karen M. Funderburk, Myriam Brossard, John Taylor, Bogdan Pasaniuc, Raj Chari, Stephen J. Chanock, Clive J. Hoggart, Florence Demenais, Jennifer H. Barrett, Matthew H. Law, Mark M. Iles, Kai Yu, Michiel Vermeulen, Leonard I. Zon, Kevin M. Brown
Format: Article
Language:English
Published: Nature Publishing Group 2020-06-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-020-16590-1
id doaj-670b26b5d219499083d912a34bb1bf00
record_format Article
spelling doaj-670b26b5d219499083d912a34bb1bf002021-06-06T11:16:27ZengNature Publishing GroupNature Communications2041-17232020-06-0111111610.1038/s41467-020-16590-1Massively parallel reporter assays of melanoma risk variants identify MX2 as a gene promoting melanomaJiyeon Choi0Tongwu Zhang1Andrew Vu2Julien Ablain3Matthew M. Makowski4Leandro M. Colli5Mai Xu6Rebecca C. Hennessey7Jinhu Yin8Harriet Rothschild9Cathrin Gräwe10Michael A. Kovacs11Karen M. Funderburk12Myriam Brossard13John Taylor14Bogdan Pasaniuc15Raj Chari16Stephen J. Chanock17Clive J. Hoggart18Florence Demenais19Jennifer H. Barrett20Matthew H. Law21Mark M. Iles22Kai Yu23Michiel Vermeulen24Leonard I. Zon25Kevin M. Brown26Division of Cancer Epidemiology and Genetics, National Cancer InstituteDivision of Cancer Epidemiology and Genetics, National Cancer InstituteDivision of Cancer Epidemiology and Genetics, National Cancer InstituteStem Cell Program and Division of Hematology/Oncology, Boston Children’s Hospital and Dana-Farber Cancer InstituteDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University NijmegenDivision of Cancer Epidemiology and Genetics, National Cancer InstituteDivision of Cancer Epidemiology and Genetics, National Cancer InstituteDivision of Cancer Epidemiology and Genetics, National Cancer InstituteDivision of Cancer Epidemiology and Genetics, National Cancer InstituteStem Cell Program and Division of Hematology/Oncology, Boston Children’s Hospital and Dana-Farber Cancer InstituteDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University NijmegenDivision of Cancer Epidemiology and Genetics, National Cancer InstituteDivision of Cancer Epidemiology and Genetics, National Cancer InstituteUniversité de Paris, UMRS-1124, Institut National de la Santé et de la Recherche Médicale (INSERM)Leeds Institute for Data Analytics, School of Medicine, University of LeedsDepartment of Human Genetics, David Geffen School of Medicine, University of California, Los AngelesGenome Modification Core, Frederick National Lab for Cancer Research, National Cancer InstituteDivision of Cancer Epidemiology and Genetics, National Cancer InstituteDepartment of Medicine, Imperial College LondonUniversité de Paris, UMRS-1124, Institut National de la Santé et de la Recherche Médicale (INSERM)Leeds Institute for Data Analytics, School of Medicine, University of LeedsStatistical Genetics, QIMR Berghofer Medical Research InstituteLeeds Institute for Data Analytics, School of Medicine, University of LeedsDivision of Cancer Epidemiology and Genetics, National Cancer InstituteDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University NijmegenStem Cell Program and Division of Hematology/Oncology, Boston Children’s Hospital and Dana-Farber Cancer InstituteDivision of Cancer Epidemiology and Genetics, National Cancer InstituteThere are more than 20 known melanoma susceptibility genes. Here, using a massively parallel reporter assay, the authors identify risk-associated variants that alter gene transcription, and demonstrate that expression of one such gene, MX2, leads to the promotion of melanoma in a zebrafish model.https://doi.org/10.1038/s41467-020-16590-1
collection DOAJ
language English
format Article
sources DOAJ
author Jiyeon Choi
Tongwu Zhang
Andrew Vu
Julien Ablain
Matthew M. Makowski
Leandro M. Colli
Mai Xu
Rebecca C. Hennessey
Jinhu Yin
Harriet Rothschild
Cathrin Gräwe
Michael A. Kovacs
Karen M. Funderburk
Myriam Brossard
John Taylor
Bogdan Pasaniuc
Raj Chari
Stephen J. Chanock
Clive J. Hoggart
Florence Demenais
Jennifer H. Barrett
Matthew H. Law
Mark M. Iles
Kai Yu
Michiel Vermeulen
Leonard I. Zon
Kevin M. Brown
spellingShingle Jiyeon Choi
Tongwu Zhang
Andrew Vu
Julien Ablain
Matthew M. Makowski
Leandro M. Colli
Mai Xu
Rebecca C. Hennessey
Jinhu Yin
Harriet Rothschild
Cathrin Gräwe
Michael A. Kovacs
Karen M. Funderburk
Myriam Brossard
John Taylor
Bogdan Pasaniuc
Raj Chari
Stephen J. Chanock
Clive J. Hoggart
Florence Demenais
Jennifer H. Barrett
Matthew H. Law
Mark M. Iles
Kai Yu
Michiel Vermeulen
Leonard I. Zon
Kevin M. Brown
Massively parallel reporter assays of melanoma risk variants identify MX2 as a gene promoting melanoma
Nature Communications
author_facet Jiyeon Choi
Tongwu Zhang
Andrew Vu
Julien Ablain
Matthew M. Makowski
Leandro M. Colli
Mai Xu
Rebecca C. Hennessey
Jinhu Yin
Harriet Rothschild
Cathrin Gräwe
Michael A. Kovacs
Karen M. Funderburk
Myriam Brossard
John Taylor
Bogdan Pasaniuc
Raj Chari
Stephen J. Chanock
Clive J. Hoggart
Florence Demenais
Jennifer H. Barrett
Matthew H. Law
Mark M. Iles
Kai Yu
Michiel Vermeulen
Leonard I. Zon
Kevin M. Brown
author_sort Jiyeon Choi
title Massively parallel reporter assays of melanoma risk variants identify MX2 as a gene promoting melanoma
title_short Massively parallel reporter assays of melanoma risk variants identify MX2 as a gene promoting melanoma
title_full Massively parallel reporter assays of melanoma risk variants identify MX2 as a gene promoting melanoma
title_fullStr Massively parallel reporter assays of melanoma risk variants identify MX2 as a gene promoting melanoma
title_full_unstemmed Massively parallel reporter assays of melanoma risk variants identify MX2 as a gene promoting melanoma
title_sort massively parallel reporter assays of melanoma risk variants identify mx2 as a gene promoting melanoma
publisher Nature Publishing Group
series Nature Communications
issn 2041-1723
publishDate 2020-06-01
description There are more than 20 known melanoma susceptibility genes. Here, using a massively parallel reporter assay, the authors identify risk-associated variants that alter gene transcription, and demonstrate that expression of one such gene, MX2, leads to the promotion of melanoma in a zebrafish model.
url https://doi.org/10.1038/s41467-020-16590-1
work_keys_str_mv AT jiyeonchoi massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT tongwuzhang massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT andrewvu massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT julienablain massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT matthewmmakowski massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT leandromcolli massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT maixu massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT rebeccachennessey massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT jinhuyin massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT harrietrothschild massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT cathringrawe massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT michaelakovacs massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT karenmfunderburk massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT myriambrossard massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT johntaylor massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT bogdanpasaniuc massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT rajchari massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT stephenjchanock massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT clivejhoggart massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT florencedemenais massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT jenniferhbarrett massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT matthewhlaw massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT markmiles massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT kaiyu massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT michielvermeulen massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT leonardizon massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
AT kevinmbrown massivelyparallelreporterassaysofmelanomariskvariantsidentifymx2asagenepromotingmelanoma
_version_ 1721394195959119872